FDA Adverse Event Death Summary report: N

ONETOUCHPING GLUCOSEMGMTSYSTEM

MDR report key: 2519313 · Received April 6, 2012

Report

Report Number
2531779-2012-02885
Event Type
Death
Date Received
April 6, 2012
Date of Event
November 3, 2010
Report Date
March 8, 2012
Manufacturer
ANIMAS CORPORATION
Product Code
LZG
PMA / PMN Number
K080639
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MI, US
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

THE WHEREABOUTS OF THE PUMP ARE UNKNOWN AT THIS TIME. ANIMAS HAS CONDUCTED A REVIEW OF THE DEVICE HISTORY RECORD FOR THIS PUMP AND CONFIRMED THAT IT WAS OPERATING WITHIN REQUIRED SPECIFICATIONS AT THE TIME OF RELEASE. IF THE DEVICE IS RETURNED, AN EVALUATION SHALL BE COMPLETED AND A SUPPLEMENTAL REPORT WILL BE FILED. NO CONCLUSIONS CAN BE MADE AT THIS TIME.

Description of Event or Problem · 1

ON (B)(6) 2012, A REPORTER CALLED ANIMAS IN RESPONSE TO MAIL ADDRESSED TO THE PATIENT AND REPORTED THAT THE PATIENT PASSED AWAY ON (B)(6) 2010. THE REPORTER ASKED THAT THE PATIENT'S NAME BE REMOVED FROM THE MAILING LIST. THE REPORTER STATED THAT THE PATIENT WAS FOUND UNCONSCIOUS AT A RESIDENCE WHICH SHE OCCUPIED AS A HOUSE-SITTER, EMERGENCY SERVICES WAS SUMMONED, AND THE PATIENT WAS PRONOUNCED DEAD AT THE HOSPITAL. IT WAS REPORTED THAT THE PATIENT WAS USING THE PUMP AT THE TIME OF DEATH. THE REPORTER NOTED THAT THE PUMP WAS TAKEN AWAY AND NEVER RETURNED. THE CAUSE OF DEATH WAS SAID TO BE DIABETIC KETOACIDOSIS (DKA) AND CARDIAC ARREST. A FAMILY MEMBER DID NOT IMPLICATE THAT THE PUMP WAS RELATED TO THE PATIENT'S DEATH. THE PATIENT'S FILE INDICATES THAT SHE FIRST BEGAN USE OF AN ANIMAS PUMP IN 2005; NO COMPLAINTS WERE MADE AGAINST THE PUMP WORN AT THE TIME OF DEATH WHICH WAS FIRST USED BY THE PATIENT AROUND (B)(6) 2009. ALTHOUGH THERE IS NO ALLEGATION THAT THE PUMP WAS RELATED TO THE PATIENT'S DEATH, THIS COMPLAINT IS BEING REPORTED BASED ON THE FOLLOWING CONCLUSION: THE PATIENT DEVELOPED DKA DURING USE OF THE INSULIN PUMP AND SUBSEQUENTLY DIED. THERE ARE NO DETAILS AVAILABLE ABOUT THE SEQUENCE OF EVENTS THAT CONTRIBUTED TO THE HYPERGLYCEMIA AS THE PATIENT WAS ALONE PRIOR TO AND AT THE TIME OF DEATH. THEREFORE, THE USE OF THE INSULIN PUMP CANNOT BE RULED OUT AS A CONTRIBUTOR TO THE PATIENT'S DEMISE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ONETOUCHPING GLUCOSEMGMTSYSTEM INSULIN INFUSION PUMP LZG ANIMAS CORPORATION ONETOUCH PING INSULIN PUMP

Patients

Seq Age Sex Outcome Treatment
1 48 YR Death